Abstract
A Discussion of Unigene Laboratories, Inc. v. Apotex, Inc.: The Standard for Prima Facie Obviousness of Pharmaceutical Formulation Claims in a Post-KSR World
Recommended Citation
Maria Doukas,
A Discussion of Unigene Laboratories, Inc. v. Apotex, Inc.: The Standard for Prima Facie Obviousness of Pharmaceutical Formulation Claims in a Post-KSR World,
11
Nw. J. Tech. & Intell. Prop.
457
(2013).
https://scholarlycommons.law.northwestern.edu/njtip/vol11/iss5/7
COinS